Objective This study was undertaken to assess the impact of immunosuppressive and
immunomodulatory therapies on the severity of coronavirus disease 2019 (COVID‐19) in people …

Traditionally, multiple sclerosis has been categorised by distinct clinical descriptors—relapsing-remitting,
secondary progressive, and primary progressive—for patient care, research, …

The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research
and clinical practice. Scientific advances in the past 7 years suggest that they might no …

The Committee of the European Concerted Action for Multiple Sclerosis (Charcot Foundation)
organised five workshops to discuss CSF analytical standards in the diagnosis of multiple …

Objective To investigate the impact of interferon‐beta (IFNβ) on disease progression in
relapsing‐remitting multiple sclerosis patients. Methods A cohort of 1,504 relapsing‐remitting …

A number of studies have been conducted with the onset of secondary progressive multiple
sclerosis as an inclusion criterion or an outcome of interest. However, a standardized …

Background: Psychiatric comorbidity is associated with lower quality of life, more fatigue,
and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). Objectives: …

Objectives: To evaluate the clinical characteristics, course and prognosis of Devic’s neuromyelitis
optica (DNO), to evaluate the prognostic role of demographic and clinical features, to …

Importance Within 2 decades of onset, 80% of untreated patients with relapsing-remitting
multiple sclerosis (MS) convert to a phase of irreversible disability accrual termed secondary …

Background and objective: We explored which clinical and biochemical variables predict
conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS…